Lupin (LUPIN) Share Price Falls 3.01% as Large Cap Pharma Stock Trades Lower
- October 8, 2026
- Posted by: Kunal Singla
- Category: News
Lupin Share Price opened lower and traded at Rs 1,898, down 3.01% from the previous close of Rs 1,957. The company’s market capitalisation stood at Rs 89,343.03 crore, keeping Lupin in the Large Cap category. Univest figures confirm the price action, but they do not point to a specific company trigger. For readers following Lupin Share Price Today, the move is relevant because it changes the intraday setup even before any fresh company news is considered. Lupin Share Price News is therefore being driven first by the price action itself, then by valuation, profitability and peer positioning. In the latest Univest figures, the healthcare name remains supported by strong ROE and ROCE, but the share price fall puts the current quote, the day range and the sector benchmark in sharper focus.
Lupin (LUPIN) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,898 |
| Previous Close | Rs 1,957 |
| Today's Move | -Rs 59.00 (-3.01%) |
| Open | Rs 1,944 |
| High | Rs 1,944 |
| Low | Rs 1,897.25 |
| Market Capitalisation | Rs 89,343.03 crore |
| Market Cap Category | Large Cap |
Lupin Share Price Today reflects a clear intraday decline. The stock opened at Rs 1,944, touched a high of Rs 1,944 and a low of Rs 1,897.25, and last traded at Rs 1,898. That means the opening level was already below the previous close, and the session stayed within a tight range near the lower end of the day’s band. Lupin Share Price also moved Rs 59 lower than the previous close, which is a 3.01% fall. With market capitalisation of Rs 89,343.03 crore, Lupin remains a Large Cap stock and continues to attract attention as a sizeable healthcare counter. For investors tracking Lupin Share Price Live, the next step is to read this move alongside the company’s profitability and valuation profile.
Lupin (LUPIN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 89,343.03 crore |
| P/E Ratio | 16.19x |
| P/B Ratio | 3.76x |
| ROE | 27.11% |
| ROCE | 28.86% |
| EPS | Rs 120.9 |
| Book Value Per Share | Rs 520.48 |
| Dividend Yield | 0.92% |
Lupin (LUPIN) fundamental metrics show P/E 16.19x, P/B 3.76x, ROE 27.11%, ROCE 28.86%. Taken on their own, these numbers offer context rather than a trading signal.
Lupin has a market capitalisation of Rs 89,343.03 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 16.19x, P/B at 3.76x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.11% and ROCE of 28.86%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 120.9, book value per share of Rs 520.48, dividend yield of 0.92%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.23x, median ROE of 11.33%, median ROCE of 13.25%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 16.19x |
| Benchmark Median P/E | 31.23x |
| Benchmark Average P/E | 45.39x |
| Benchmark P/E Range | 3.4x to 616.23x |
| Company P/B Ratio | 3.76x |
| Benchmark Median P/B | 2.71x |
| Benchmark Average P/B | 4.05x |
| Company ROE | 27.11% |
| Benchmark Median ROE | 11.33% |
| Benchmark Average ROE | 10.08% |
| Company ROCE | 28.86% |
| Benchmark Median ROCE | 13.25% |
| Benchmark Average ROCE | 12.99% |
| Company Market Capitalisation | Rs 89,343.03 crore |
| Benchmark Median Market Cap | Rs 771.43 crore |
| Benchmark Average Market Cap | Rs 13,461.56 crore |
Lupin (LUPIN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Lupin (LUPIN) has a P/E ratio of 16.19x, which is below the benchmark median of 31.23x, a difference of -48.16%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Lupin (LUPIN) has a ROE of 27.11%, which is above the benchmark median of 11.33%, a difference of +139.28%. Lupin (LUPIN) has a ROCE of 28.86%, which is above the benchmark median of 13.25%, a difference of +117.81%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,18,683.95 | 34.61 | 4.84 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,41,310.94 | 83.04 | 13.75 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,73,078.79 | 78.96 | 19.19 | 26.76 | 19.27 |
| Laurus Labs | LAURUSLABS | 1,11,433.99 | 99.43 | 19.28 | 18.31 | 18.2 |
| Zydus Lifesciences | ZYDUSLIFE | 1,11,022.18 | 24.7 | 4.13 | 19.69 | 21.39 |
Lupin (LUPIN) has a P/E ratio of 16.19x compared with the displayed peer median of 78.96x. The comparison is relative and should not be read as a recommendation. Its ROE of 27.11% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 28.86% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Lupin (LUPIN) has a market capitalisation of Rs 89,343.03 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Lupin
- Lupin Share Price fell 3.01% to Rs 1,898, which makes today’s price action the first item to watch.
- Lupin Share Price Today sits well below the previous close of Rs 1,957, keeping the intraday move visible.
- The Large Cap tag and Rs 89,343.03 crore market capitalisation make Lupin Share Price important within healthcare.
- P/E of 16.19, ROE of 27.11% and ROCE of 28.86% give Lupin Share Price a distinct fundamental profile.
- Lupin Share Price News also stands out because the stock trades below the industry median P/E while remaining above the industry median P/B.
About Lupin
Lupin is a healthcare company in the Pharmaceuticals & Drugs industry. Its business profile is read through the lens of pharma operations, where revenue generation is tied to the company’s product and market mix within the sector. Lupin Share Price therefore belongs to a business whose valuation is shaped by earnings quality, capital efficiency and industry comparison rather than by a single short-term move. For Lupin Stock News readers, the company sits in a large, competitive healthcare universe where return ratios and earnings multiples matter. The latest Univest figures place Lupin in a position where its fundamentals can be compared directly with other listed drug makers of similar scale.
Track Lupin Share Price on Univest
Use Lupin (LUPIN) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Track Lupin Share Price on Univest for live price updates, valuation ratios, 52-week levels and market insights in one place. Lupin Share Price Today, sector context and peer comparison are all available in a format designed for quick reading. Univest also helps readers follow Lupin Stock News, Lupin Share Price Live and Lupin Stock Analysis without losing the broader fundamental picture.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Lupin Share Price falling today?
Ans. Lupin Share Price fell 3.01% to Rs 1,898, with the latest trade below the previous close of Rs 1,957. Univest figures confirm the price action, but they do not point to a specific company trigger.
What is Lupin Share Price Today?
Ans. Lupin Share Price Today is Rs 1,898. The stock traded between Rs 1,897.25 and Rs 1,944 in the session, after opening at Rs 1,944 and moving below the previous close of Rs 1,957.
What is Lupin’s market capitalisation?
Ans. Lupin’s market capitalisation stands at Rs 89,343.03 crore. That places the company in the Large Cap category and gives context to Lupin Share Price as a major healthcare stock rather than a smaller listed name.
How does Lupin’s valuation compare with the sector?
Ans. Lupin Share Price trades on a P/E of 16.19 versus the sector median of 31.23 and an average of 45.39. Its P/B of 3.76 is above the median of 2.71 and below the average of 4.05.
What do ROE and ROCE show for Lupin?
Ans. Lupin reports ROE of 27.11% and ROCE of 28.86%. Both are above the industry median and average in the pharmaceuticals set, which gives Lupin Share Price a strong profitability and capital-efficiency backdrop.
What is Lupin’s EPS and book value?
Ans. Lupin’s EPS is Rs 120.9 and book value is Rs 520.48. These two figures help readers judge Lupin Share Price against earnings per share and accounting net worth per share in the latest Univest figures.
Does Lupin pay a dividend?
Ans. Lupin’s dividend yield is 0.92%. That makes dividend yield a part of Lupin Share Price analysis, but it should be read as a historical or current payout measure rather than a guarantee for future distributions.
How does Lupin compare with listed pharma peers?
Ans. Lupin Share Price sits below Sun Pharma, Divi’s Laboratories, Torrent Pharma and Laurus Labs on valuation multiples, while Zydus Lifesciences is closer on P/E. Lupin’s ROE and ROCE remain comparatively strong in the peer set.
What should investors monitor next in Lupin Share Price?
Ans. Investors can monitor whether Lupin Share Price holds near the day’s low of Rs 1,897.25, how it trades relative to the previous close of Rs 1,957, and whether the valuation gap versus peers narrows or widens.
